Effects of Eprosartan in Chronic Kidney Disease

Journal of Clinical and Basic Cardiology 2005; 8 (1-4): 15-17
Journal of Clinical and Basic Cardiology 2006; 9 (Sonderheft 1): 13-15

PDF    Summary    Figures   




Keywords: Angiotensin-II-Antagonist,  Angiotensin-II-Rezeptorblockade,  Eprosartan,  Hypertonie,  Kardiologie,  Nierenerkrankung,  Sympathikus,  angiotensin II antagonist,  angiotensin receptor blockade,  cardiology,  chronic kidney disease,  Eprosartan,  hypertension,  sympathetic nervous system

Increased activities of the renin system and the sympathetic nervous system are key contributors to the pathogenesis of hypertension in chronic kidney disease patients. Eprosartan is an angiotensin II receptor antagonist, which effectively reduces muscle sympathetic nerve activity (MSNA) in chronic kidney disease patients.